Cargando…

Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders

Detalles Bibliográficos
Autores principales: Routhu, Kasi Viswanath, Veeraraghavan, Sridhar, Merikapudi, Gayatri Swaroop, G, Babu, Viswanadha, Srikant, Vakkalanka, Swaroop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643267/
http://dx.doi.org/10.1186/1939-4551-6-S1-P90
_version_ 1782268289347485696
author Routhu, Kasi Viswanath
Veeraraghavan, Sridhar
Merikapudi, Gayatri Swaroop
G, Babu
Viswanadha, Srikant
Vakkalanka, Swaroop
author_facet Routhu, Kasi Viswanath
Veeraraghavan, Sridhar
Merikapudi, Gayatri Swaroop
G, Babu
Viswanadha, Srikant
Vakkalanka, Swaroop
author_sort Routhu, Kasi Viswanath
collection PubMed
description
format Online
Article
Text
id pubmed-3643267
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36432672013-05-08 Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders Routhu, Kasi Viswanath Veeraraghavan, Sridhar Merikapudi, Gayatri Swaroop G, Babu Viswanadha, Srikant Vakkalanka, Swaroop World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643267/ http://dx.doi.org/10.1186/1939-4551-6-S1-P90 Text en Copyright ©2013 Routhu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Routhu, Kasi Viswanath
Veeraraghavan, Sridhar
Merikapudi, Gayatri Swaroop
G, Babu
Viswanadha, Srikant
Vakkalanka, Swaroop
Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
title Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
title_full Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
title_fullStr Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
title_full_unstemmed Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
title_short Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
title_sort mechanisims of asthma and allergic disease – 1094. pre-clinical characterization of rp3133, a novel and potent crac channel inhibitor for the treatment of respiratory disorders
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643267/
http://dx.doi.org/10.1186/1939-4551-6-S1-P90
work_keys_str_mv AT routhukasiviswanath mechanisimsofasthmaandallergicdisease1094preclinicalcharacterizationofrp3133anovelandpotentcracchannelinhibitorforthetreatmentofrespiratorydisorders
AT veeraraghavansridhar mechanisimsofasthmaandallergicdisease1094preclinicalcharacterizationofrp3133anovelandpotentcracchannelinhibitorforthetreatmentofrespiratorydisorders
AT merikapudigayatriswaroop mechanisimsofasthmaandallergicdisease1094preclinicalcharacterizationofrp3133anovelandpotentcracchannelinhibitorforthetreatmentofrespiratorydisorders
AT gbabu mechanisimsofasthmaandallergicdisease1094preclinicalcharacterizationofrp3133anovelandpotentcracchannelinhibitorforthetreatmentofrespiratorydisorders
AT viswanadhasrikant mechanisimsofasthmaandallergicdisease1094preclinicalcharacterizationofrp3133anovelandpotentcracchannelinhibitorforthetreatmentofrespiratorydisorders
AT vakkalankaswaroop mechanisimsofasthmaandallergicdisease1094preclinicalcharacterizationofrp3133anovelandpotentcracchannelinhibitorforthetreatmentofrespiratorydisorders